First Time Loading...
P

POINT Biopharma Global Inc
NASDAQ:PNT

Watchlist Manager
POINT Biopharma Global Inc
NASDAQ:PNT
Watchlist
Price: 12.5 USD Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

PNT Price Targets Summary
POINT Biopharma Global Inc

Wall Street analysts forecast PNT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PNT is 12.5 USD .

PNT Lowest Forecast
Wall Street Target
Not Available
PNT Average Forecast
Wall Street Target
12.5 USD
0% Downside
PNT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
12.5 USD
0% Upside
Highest
Price Target
Not Available
POINT Biopharma Global Inc Competitors:
Price Targets
UTHR
United Therapeutics Corp
19% Upside
OXB
Oxford BioMedica PLC
48% Upside
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
RNA
Avidity Biosciences Inc
96% Upside
UTHR
United Therapeutics Corp
19% Upside
OXB
Oxford BioMedica PLC
48% Upside
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
RNA
Avidity Biosciences Inc
96% Upside
PRLD
Prelude Therapeutics Inc
57% Upside
ADAG
Adagene Inc
416% Upside
ASND
Ascendis Pharma A/S
31% Upside
MRUS
Merus NV
38% Upside

Revenue
Forecast

Revenue Estimate
POINT Biopharma Global Inc

The compound annual growth rate of POINT Biopharma Global Inc's revenue for the next 4 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
POINT Biopharma Global Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
POINT Biopharma Global Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
PNT intrinsic value, competitors valuation, and company profile.
DCF Valuation
PNT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PNT stock valuation using valuation multiples.
Wall Street Estimates
PNT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PNT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PNT's stock price target?
Price Target
12.5 USD

According to Wall Street analysts, the average 1-year price target for PNT is 12.5 USD .

What is POINT Biopharma Global Inc's Revenue forecast?
Projected CAGR
-10%

The compound annual growth rate of POINT Biopharma Global Inc's revenue for the next 4 years is -10%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.